EGFR-dependent mechanisms of resistance to osimertinib determined by ctDNA NGS analysis identify patients with better outcome

BACKGROUND: Osimertinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) that is highly selective for EGFR(T790M) subclones in patients with EGFR(sensitizing) non-small cell lung cancer (NSCLC). Unfortunately, all patients develop resistance through EGFR-dependent or EGF...

Descripción completa

Detalles Bibliográficos
Autores principales: Vendrell, Julie A., Quantin, Xavier, Aussel, Audrey, Solassol, Isabelle, Serre, Isabelle, Solassol, Jérôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674606/
https://www.ncbi.nlm.nih.gov/pubmed/35004240
http://dx.doi.org/10.21037/tlcr-21-679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674606/
https://www.ncbi.nlm.nih.gov/pubmed/35004240
http://dx.doi.org/10.21037/tlcr-21-679

Ejemplares similares